Araujo A, Martin F (2020) Human T leukaemia Type 1 and COVID-19. Pathogens 9:438

Article  CAS  PubMed  PubMed Central  Google Scholar 

Araujo A, Martin F (2022) SARS-CoV-2 vaccination of people living with human T leukaemia virus type 1. Sex Transm Infect 98:154

Article  PubMed  Google Scholar 

Dashdorj NJ, Wirz OF, Roltgen K, Haraguchi E, Buzzanco AS 3rd, Sibai M, Wang H, Miller JA, Solis D, Sahoo MK, Arunachalam PS, Lee AS, Shah MM, Liu J, Byambabaatar S, Bat-Ulzii P, Enkhbat A, Batbold E, Zulkhuu D, Ochirsum B, Khurelsukh T, Dalantai G, Burged N, Baatarsuren U, Ariungerel N, Oidovsambuu O, Bungert AS, Genden Z, Yagaanbuyant D, Mordorj A, Pulendran B, Chinthrajah S, Nadeau KC, Jardetzky T, Wilbur JL, Wohlstadter JN, Sigal GB, Pinsky BA, Boyd SD, Dashdorj ND (2021) Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia. Cell Host Microbe 29:1738–1743

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu Y, Chen F, Cui L, Zhao Y, Zhang H, Fu S, Zhang J (2021) Immunological analysis of people in Northeast China after SARS-CoV-2 inactivated vaccine injection. Vaccines 9:1028

Article  CAS  PubMed  PubMed Central  Google Scholar 

Futsch N, Mahieux R, Dutartre H (2017) HTLV-1, the other pathogenic yet neglected human retrovirus: from transmission to therapeutic treatment. Viruses 10:1

Article  PubMed  PubMed Central  Google Scholar 

Gonçalves DU, Proietti FA, Ribas JGR, Araújo MG, Pinheiro SR, Guedes AC, Carneiro-Proietti ABF (2010) Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev 23:577–589

Article  PubMed  PubMed Central  Google Scholar 

Gouya MM, Seif-Farahi K, Hemmati P (2023) An overview of Iran’s actions in response to the COVID-19 pandemic and in building health system resilience. Front Public Health 11:1073259

Article  PubMed  PubMed Central  Google Scholar 

Heidari M, Sayfouri N, Jafari H (2022) Consecutive Waves of COVID-19 in Iran: Various Dimensions and Probable Causes. Disaster Med Public Health Prep 17:e136

Article  PubMed  Google Scholar 

Herzog Tzarfati K, Gutwein O, Apel A, Rahimi-Levene N, Sadovnik M, Harel L, Benveniste-Levkovitz P, Bar Chaim A, Koren-Michowitz M (2021) BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies. Am J Hematol 96:1195–1203

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirons A, Khoury G, Purcell DF (2021) Human T-cell lymphotropic virus type-1: A lifelong persistent infection, yet never truly silent. Lancet Infect Dis 21:e2–e10

Article  CAS  PubMed  Google Scholar 

Holt SG, Mahmoud S, Ahmed W, Acuna JM, Al Madani AK, Eltantawy I, Zaher WA, Goodier GJ, Al Kaabi NA, Al Obaidli AA (2022) An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates. Nephrology (carlton) 27:260–268

Article  CAS  PubMed  Google Scholar 

Kak G, Raza M, Tiwari BK (2018) Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases. Biomol Concepts 9:64–79

Article  CAS  PubMed  Google Scholar 

Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan ST (2020) COVID-19: a global challenge with old history, epidemiology and progress so far. Molecules 26:39

Article  PubMed  PubMed Central  Google Scholar 

Lee A, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, Sundar R, Soon YY (2022) Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 376:e068632

Article  PubMed  Google Scholar 

Lijeskić O, Klun I, Stamenov Djaković M, Gligorić N, Štajner T, Srbljanović J, Djurković-Djaković O (2021) Prospective cohort study of the kinetics of specific antibodies to SARS-CoV-2 infection and to four SARS-CoV-2 vaccines available in Serbia, and vaccine effectiveness: a 3-month interim report. Vaccines 9:1031

Article  PubMed  PubMed Central  Google Scholar 

Madhi SA, Koen AL, Izu A, Fairlie L, Cutland CL, Baillie V, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE (2021) Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. The Lancet HIV 8:e568–e580

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moss P (2022) The T cell immune response against SARS-CoV-2. Nat Immunol 23:186–193

Article  CAS  PubMed  Google Scholar 

Paludan SR, Mogensen TH (2022) Innate immunological pathways in COVID-19 pathogenesis. Sci Immunol 7:eabm5505

Quaresma JA, Yoshikawa GT, Koyama RV, Dias GA, Fujihara S, Fuzii HT (2015) HTLV-1, immune response and autoimmunity. Viruses 8:5

Article  PubMed  PubMed Central  Google Scholar 

Sajjadi S, Hejazi S, Ravanshad S, Jafarzadeh Esfehani R (2022) Human T-lymphotropic virus type 1 and novel coronavirus disease 2019; More complex than just a simple coinfection. Gene 834:146550

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schierhout G, McGregor S, Gessain A, Einsiedel L, Martinello M, Kaldor J (2020) Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis 20:133–143

Article  CAS  PubMed  Google Scholar 

Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, Du P (2021) Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep 11:6283

Article  PubMed  PubMed Central  Google Scholar 

Tesoriero JM, Swain CE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, Gonzalez CJ, Udo T, Morne JE, Hart-Malloy R (2021) COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Netw Open 4:e2037069

Article  PubMed  PubMed Central  Google Scholar 

Tian L, Elsheikh EB, Patrone PN, Kearsley AJ, Gaigalas AK, Inwood S, Lin-Gibson S, Esposito D, Wang L (2021) Towards quantitative and standardized serological and neutralization assays for COVID-19. Int J Mol Sci 22:2723

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willems L, Hasegawa H, Accolla R, Bangham C, Bazarbachi A, Bertazzoni U, de Freitas Carneiro-Proietti AB, Cheng H, Chieco-Bianchi L, Ciminale V (2017) Reducing the global burden of HTLV-1 infection: an agenda for research and action. Antiviral Res 137:41–48

Article  CAS  PubMed  Google Scholar 

World Health Organization (2023) Available from: https://covid19.who.int/region/emro/country/ir. Accessed 27 Aug 2023

Yau K, Abe KT, Naimark D, Oliver MJ, Perl J, Leis JA, Bolotin S, Tran V, Mullin SI, Shadowitz E (2021) Evaluation of the SARS-CoV-2 antibody response to the BNT162b2 vaccine in patients undergoing hemodialysis. JAMA Netw Open 4:e2123622–e2123622

Article  PubMed  PubMed Central  Google Scholar